Shrinking lung syndrome is seen in?
**Core Concept**
Shrinking lung syndrome is a rare condition characterized by a decrease in lung volume, leading to shortness of breath and decreased lung function. It is often associated with chronic autoimmune disorders, such as systemic lupus erythematosus (SLE). The pathophysiology involves diaphragmatic dysfunction, which leads to a reduction in lung expansion.
**Why the Correct Answer is Right**
Shrinking lung syndrome is typically seen in patients with SLE, where the autoimmune response leads to inflammation and damage to the diaphragm and surrounding tissues. This results in a restrictive pattern of lung disease, characterized by a reduction in lung volumes and capacities. The diaphragmatic dysfunction in SLE is thought to be mediated by the deposition of immune complexes and the activation of various inflammatory cells, leading to fibrosis and scarring of the diaphragm.
**Why Each Wrong Option is Incorrect**
**Option A:** This is incorrect because while SLE can cause respiratory complications, such as pleurisy and pneumonitis, shrinking lung syndrome is a specific condition characterized by diaphragmatic dysfunction.
**Option B:** This is incorrect because chronic obstructive pulmonary disease (COPD) is a different condition characterized by airflow limitation, usually due to smoking or chronic exposure to pollutants. Shrinking lung syndrome is a restrictive condition, not an obstructive one.
**Option C:** This is incorrect because pulmonary embolism is a condition characterized by the blockage of a pulmonary artery, leading to acute respiratory distress. Shrinking lung syndrome is a chronic condition with a different pathophysiology.
**Clinical Pearl / High-Yield Fact**
Shrinking lung syndrome is often associated with diaphragmatic elevation on chest radiographs and a characteristic "boxy" appearance on pulmonary function tests. This condition should be considered in patients with SLE who present with shortness of breath and decreased lung function.
**Correct Answer:** C.